Are IV Therapies safe
While we focus on a variety of skin and wellness treatments, understanding the broader landscape of metabolic health helps you make better decisions for your long-term lifestyle

According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients requiring lifelong hydroxocobalamin 1mg intramuscularly every 23 months following initial loading doses Patients with gastrointestinal disorders including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians though oral supplementation is usually sufficient unless malabsorption is present Elderly patients who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women with confirmed deficiency (hydroxocobalamin for malabsorption

Our patches come with a clear backing designed specifically to make sure every patch is usable, every time
What the Research Actually Shows Honestly assessing the state of BPC-157 evidence: preclinical research demonstrates plausible biological mechanisms and tissue-level effects in animal models
Semaglutides lower cost of control than liraglutide offers an economic argument for its potential inclusion in the list of reimbursed medicinal products